Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep Ltd (DE:YP1B)
BERLIN:YP1B
Immutep Ltd (YP1B) Stock Price & Analysis
0 Followers
YP1B Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.12 - €0.30
Previous Close€0.2
Volume0.00
Average Volume (3M)N/A
Market Cap
€250.28M
Enterprise Value€176.39M
Total Cash (Recent Filing)AU$123.42M
Total Debt (Recent Filing)AU$1.23M
Price to Earnings (P/E)N/A
Beta1.32
Next Earnings
Aug 28, 2024EPS Estimate
-€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding879,089,453
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.06
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.65
Price to Sales (P/S)54.26
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.47Price Target Upside136.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Immutep Ltd News
PremiumCompany Announcements
Immutep’s Innovative Cancer Therapy Shows Promise
PremiumCompany Announcements
Immutep Announces Encouraging Clinical Results
PremiumCompany Announcements
Immutep’s Promising Trial Results for Cancer Therapy
PremiumCompany Announcements
Immutep Advances Novel Autoimmune Therapy with Phase I TrialYP1B FAQ
What was Immutep Ltd’s price range in the past 12 months?
Immutep Ltd lowest stock price was €0.12 and its highest was €0.30 in the past 12 months.
What is Immutep Ltd’s market cap?
Currently, no data Available
When is Immutep Ltd’s upcoming earnings report date?
Immutep Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 118 days.
How were Immutep Ltd’s earnings last quarter?
Immutep Ltd released its earnings results on Feb 27, 2024. The company reported -€0.017 earnings per share for the quarter, missing the consensus estimate of -€0.012 by -€0.005.
Is Immutep Ltd overvalued?
According to Wall Street analysts Immutep Ltd’s price is currently Undervalued.
Does Immutep Ltd pay dividends?
Immutep Ltd does not currently pay dividends.
What is Immutep Ltd’s EPS estimate?
Immutep Ltd’s EPS estimate is -€0.01.
How many shares outstanding does Immutep Ltd have?
Currently, no data Available
What happened to Immutep Ltd’s price movement after its last earnings report?
Immutep Ltd reported an EPS of -€0.017 in its last earnings report, missing expectations of -€0.012. Following the earnings report the stock price went up 3.158%.
Which hedge fund is a major shareholder of Immutep Ltd?
Currently, no hedge funds are holding shares in DE:YP1B
---
Immutep Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€0.47 (136.74% Upside)
€0.47 (136.74% Upside)
Blogger Sentiment
Bullish
DE:YP1B Sentiment 95%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.50%
12-Months-Change
Fundamentals
Return on Equity
-41.05%
Trailing 12-Months
Asset Growth
44.82%
Trailing 12-Months
Company Description
Immutep Ltd
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
YP1B Stock 12 Months Forecast
Average Price Target
€0.47
▲(136.74% Upside)
Technical Analysis
Best Analysts Covering YP1B
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+85.83%
reiterated a buy rating 11 months ago
Copying Tanushree Jain's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +85.83% per trade.
---